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neurosecretory vesicles undergo docking and priming before Ca2 + -dependent fusion with 
the plasma membrane. Although de novo synthesis of phosphatidylinositol(4,5)bisphosphate 
(PtdIns(4,5)P2) is required for exocytosis, its precise contribution is still unclear. Here we show 
that inhibition of the p110δ isoform of PI3-kinase by IC87114 promotes a transient increase in 
PtdIns(4,5)P2, leading to a potentiation of exocytosis in chromaffin cells. We then exploit this 
pathway to examine the effect of a transient PtdIns(4,5)P2 increase on neurosecretory vesicles 
behaviour, outside the context of a secretagogue stimulation. our results demonstrate that a rise 
in PtdIns(4,5)P2 is sufficient to promote the mobilization and recruitment of secretory vesicles 
to the plasma membrane via Cdc42-mediated actin reorganization. PtdIns(4,5)P2, therefore, 
orchestrates the actin-based conveyance of secretory vesicles to the plasma membrane. 
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Neuronal and hormonal communication relies on the regu-lated release of neurotransmitters stored in secretory vesi-cles through a process known as exocytosis. In chromaffin 
cells, most vesicles are separated from the plasma membrane by a 
dense cortical network of actin filaments. Following stimulation 
of exocytosis this restrictive barrier is disrupted, allowing vesi-
cles to translocate to the plasma membrane and undergo fusion1. 
Such disruption is initiated by Ca2 +  and mediated by proteins such 
as scinderin1 and MARCKS2. A more active role for actin during 
vesicle exocytosis has recently been suggested3.
Phosphoinositides have a critical role in exocytosis4–11. First, 
manipulation of phospholipase C activity affects exocytosis5. Sec-
ond, phosphatidylinositol transfer protein (PITPα) and phos-
phatidylinositol 4-phosphate 5-kinase (PI4P5K) are essential for 
ATP-dependent priming6. Third, PtdIns(4,5)P2 sequestration by 
the Phospholipase C δ1 Pleckstrin homology domain (PH-PLCδ1) 
domain or redistribution of PtdIns(4,5)P2 to endocytic organelles 
by expression of a constitutively active ARF6 mutant inhibits secre-
tion4,7. Fourth, intracellular application of PtdIns(4,5)P2 increases 
the size of the readily releasable pools in pancreatic β cells, and 
neutralization of a PtdIns(4,5)P2 effector, Ca2 + -dependent activa-
tor protein for secretion (CAPS), also abolishes secretion12. Finally, 
manipulation of PtdIns(4,5)P2 levels using a pan-PI3-kinase (PI3K) 
inhibitor has revealed that PtdIns(4,5)P2 controls the readily releas-
able pool of secretory vesicles8. These lines of evidence point to a 
role for PtdIns(4,5)P2 in mediating ATP-dependent priming, which 
is known to be a relatively early event in exocytosis.
Our current knowledge of PtdIns(4,5)P2 effectors is mainly 
restricted to the latest steps of exocytosis13. However, a number of 
additional PtdIns(4,5)P2 effectors, including CAPS14, are likely to 
act during the priming stage. De novo synthesis of PtdIns(4,5)P2 is 
a critical step in the ATP-dependent priming that occurs following 
stimulation of exocytosis6. One of the key issues in understanding the 
role of PtdIns(4,5)P2 in secretion is that it has not yet been possible to 
dissect its actual contribution in isolation from the context of secre-
tagogue stimulation. Short-term application of the pan PI3-kinase 
inhibitor LY294002 has been shown to elicit a transient increase in 
PtdIns(4,5)P2 that correlates with a potentiation of secretion8. Such 
PtdIns(4,5)P2 was detected in isolated plasma membrane sheets from 
chromaffin cells in the absence of Ca2 +  and cytosol, suggesting that the 
machinery responsible for PtdIns(4,5)P2 synthesis could be present 
on the plasma membrane. To investigate this contribution, we char-
acterized the nature of this PI3K-sensitive and cytosol-independent 
pathway and then exploited it to investigate the role of PtdIns(4,5)P2 
in exocytosis. Our results reveal that the increase in PtdIns(4,5)P2 elic-
ited through pharmacological inhibition of class I PI3Kδ is sufficient 
to promote Cdc42-mediated actin reorganization that allows the 
translocation of secretory granules towards the plasma membrane.
Results
Inhibition of PI3Kδ by IC87114 potentiates exocytosis. 
PtdIns(4,5)P2 levels have been reported to transiently increase 
in response to treatment with LY294002, a broad-spectrum PI3K 
inhibitor 8. Although this effect correlated with an increase in 
secretion, the actual contribution of PI3K remained unclear15. We 
hypothesize that LY294002 could promote a transient increase in 
PtdIns(4,5)P2 levels via perturbation of the dynamic equilibrium 
between PtdIns(4,5)P2 and PtdIns(3,4,5)P3 controlled by a class 
I PI3K and the 3-phosphatase PTEN. The recent development 
of isoform-selective class I PI3K inhibitors allowed us to test the 
possible contribution of this class of enzymes to exocytosis, and their 
possible contribution to PtdIns(4,5)P2 production. Cultured bovine 
chromaffin cells were incubated with increasing concentrations 
of isoform-specific inhibitors for PI3Kβ (TGX-221)16, PI3Kδ 
(IC87114)17 or PI3Kγ (AS252424)18 and briefly stimulated using 
barium chloride (Ba2 + ) in the continuing presence of inhibitors 
(Fig. 1a–c). IC87114, a potent inhibitor of PI3Kδ, had a potentiating 
effect on Ba2 + -stimulated catecholamine release from chromaffin 
cells (Fig. 1b). Interestingly, this was observed with as little as 1 min 
of IC87114 preincubation (Fig. 1d). In the absence of secretagogue, 
IC87114 had no effect on basal catecholamine release (Fig. 1e). We 
hypothesized that IC87114-mediated potentiation of exocytosis 
was promoted by a local increase in PtdIns(4,5)P2 and should 
therefore be independent of the type of voltage-gated Ca2 +  channels 
activated by the secretagogue. To bypass Ca2 +  channels, digitonin-
permeabilized chromaffin cells were incubated with increasing 
concentrations of IC87114 before stimulation with EGTA-buffered 
Ca2 + . Under these conditions, IC87114-induced potentiation was 
still apparent (Fig. 1f). We also demonstrated that IC87114 did not 
affect activity-dependent Ca2 +  influx in chromaffin cells loaded 
with the Ca2 +  indicator Fluo4/AM (Supplementary Fig. S1).
PI3Kδ has recently been shown to negatively regulate the 3-
phosphatase PTEN19. In response to IC87114, the dynamic equilib-
rium between PtdIns(4,5)P2 and PtdIns(3,4,5)P3 should therefore 
be shifted towards PtdIns(4,5)P2 through the increased activity of 
PTEN leading to a transient rise in PtdIns(4,5)P2. We tested this 
hypothesis by preincubating chromaffin cells with VO-OHpic, a 
PTEN-specific inhibitor20. Whereas IC87114 promoted a signifi-
cant potentiation of Ca2 + -stimulated catecholamine release from 
digitonin-permeabilized chromaffin cells (Fig. 1g), preincubating 
cells with VO-OHpic abolished this effect (Fig. 1e). Importantly, 
VO-OHpic treatment alone had no effect on basal or Ba2 + -stimu-
lated release (Fig. 1h). These data suggest that PI3Kδ inhibition 
potentiates exocytosis by increasing PtdIns(4,5)P2 levels not only 
by preventing production of PtdIns(3,4,5)P3 by PI3Kδ, but also 
through the dephosphorylation of PtdIns(3,4,5)P3 by the disinhib-
ited PTEN.
PI3Kδ and PTEN are expressed in chromaffin cells. Recent evidence 
has shown that PI3Kδ is highly expressed in the central nervous sys-
tem21. To determine whether PI3Kδ and PTEN are also expressed in 
chromaffin cells, we performed a subcellular fractionation and found 
that both proteins were present in both the cytosol and membrane 
fractions of these cells (Fig. 1i). p110δ, the catalytic subunit of PI3Kδ, 
was restricted to light membranes (100KP and fraction 2) whereas 
PTEN had a broader distribution, with a first peak similar to that 
of SNAP-25 (synaptosome-associated protein of 25,000 daltons), a 
plasma membrane marker, and a second peak corresponding to the 
heavy membrane-containing fractions 11 and 12 that are enriched for 
the secretory granule marker, vesicle-associated membrane protein 
(VAMP2) (Fig. 1i). This suggests that a pool of PI3Kδ and PTEN is 
present on the plasma membrane, as previously suggested22, and that 
an extra pool of PTEN may also be present on secretory vesicles.
p110δ inhibition by IC87114 increases PtdIns(4,5)P2 levels. Our 
experiments pointed to a role for PI3Kδ in regulating PtdIns(4,5)P2 
synthesis and exocytosis. To further test this idea, we isolated chro-
maffin cells from wild-type and mutant knock-in–knockout mice 
in which both p110δ alleles have been replaced by a kinase-dead 
mutant p110D910A/D910A23. Both wild-type and mutant cell types were 
treated with IC87114 and the level of PtdIns(4,5)P2 analysed by thin 
layer chromatography (TLC) followed by an overlay assay using the 
PtdIns(4,5)P2-specific antibody 2C11 (ref. 24). IC87114 promoted 
a significant increase in PtdIns(4,5)P2 in the wild-type cells (Fig. 2a), 
but not in the mutant cells (Fig. 2b). Chromaffin cells extracted 
from the mutant mice had slightly less PtdIns(4,5)P2, although this 
was not statistically significant (Supplementary Fig. S2).
We next repeated this experiment using bovine chromaffin 
cells and further tested whether the IC87114-mediated increase 
in PtdIns(4,5)P2 could be prevented by preincubation of the cells 
with the PTEN-specific inhibitor, VO-OHpic. A similar significant 
increase in PtdIns(4,5)P2 levels was detected in bovine chromaffin 
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cells treated with IC87114, an effect which was also sensitive to VO-
OHpic pretreatment (Fig. 2c). We also analysed phosphoinositide 
levels by high-performance liquid chromatography25. Bovine chro-
maffin cells were 32P-radiolabelled for 2 h before being treated 
with either DMSO or IC87114 for 5 min. Phosphoinositides were 
then extracted, deacylated and analysed on a SAX–HPLC column. 
IC87114 treatment was found to promote a significant increase 
(154 ± 9%) of total cellular PtdIns(4,5)P2 pools compared with vehi-
cle alone (Supplementary Fig. S2). Unfortunately, we could not con-
sistently detect PtdIns(3,4,5)P3 under our experimental conditions, 
probably due to the scarcity of the lipid. Consequently, our findings 
point to a possible role of plasma membrane PTEN in generating 
PtdIns(4,5)P2 in response to PI3Kδ specific inhibition, although 
we cannot exclude the possibility of a parallel contribution from 
other pathway(s).
PtdIns(4,5)P2 signal induced by p110δ inhibition. To gain a deeper 
insight into the kinetics of the plasma membrane PtdIns(4,5)P2 gen-
eration elicited by IC87114, bovine chromaffin cells were transfected 
with PH-PLCδ1 fused to EGFP (PH-PLCδ1-EGFP), a specific probe 
for PtdIns(4,5)P2 (ref. 26) and examined by total internal reflection 
fluorescence (TIRF) microscopy. The intensity of the PH-PLCδ1-
EGFP fluorescent signal on the plasma membrane clearly increased 
in response to IC87114 through cytosolic recruitment (Fig. 2d; 
Supplementary Movie 1). Although the increase was detected 
throughout the examined footprint, local hotspots were observed in 
which the intensity increase was higher than in other regions of the 
plasma membrane (Fig. 2d). Importantly, IC87114 did not increase 
PtdIns(4,5)P2 levels after preincubation of the cells with VO-OHpic 
(Fig. 2e–g; Supplementary Movie 2). In an attempt to simultane-
ously detect the rise in PtdIns(4,5)P2 and a drop in PtdIns(3,4,5)P3, 
chromaffin cells were transfected with either Akt-PH-GFP or Btk-
PH-GFP (PtdIns(3,4,5)P3 probes) with PH-PLCδ1-mRFP. However, 
both Akt-PH-GFP and Btk-PH-GFP abolished the IC87114-medi-
ated rise in PtdIns(4,5)P2 and the intensity of their staining at the 
plasma membrane did not change (Supplementary Fig. S3). One 
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Figure 1 | Effect of isoform-selective PI3K inhibitors on catecholamine release from chromaffin cells. Cultured bovine chromaffin cells were briefly 
washed with buffer A and incubated with increasing concentrations of (a) TGX-221 (b) IC87114 or (c) As252424 before being further stimulated using 
barium chloride (2 mm) for 2 min in the continuing presence of inhibitors. (d) Chromaffin cells were treated with IC87114 (1 µm) for the indicated time 
period before being stimulated using barium chloride (2 mm) for 2 min. (e) Chromaffin cells were incubated with or without IC87114 for 20 min before 
being stimulated using barium chloride (2 mm) for 2 min. (f) Chromaffin cells were treated with the indicated concentrations of IC87114 for 5 min before 
stimulation using digitonin (20 µm) permeabilization in the presence of 10 µm Ca2 +  and 2 mm mgATP in KGEP buffer. (g) Chromaffin cells were  
pre-incubated with or without Vo-oHpic (100 nm) in buffer A before the addition of IC87114 (1 µm). Cells were then stimulated as described above.  
(h) Chromaffin cells were pre-treated with Vo-oHpic (100 nm) before being stimulated using barium chloride (2 mm) for 2 min. Aliquots of the 
supernatant were removed and assayed fluorimetrically for catecholamine content. Data are expressed as mean ± s.e.m. n = 8, **student’s t-test, P < 0.01, 
representative experiments carried out at least 4 times in octuplicate. (i) subcellular fractions were prepared from bovine adrenal medulla (12KP and 
12Ksn = pellet and supernatant from 12,000 gav spin; 100KP and 100Ksn = pellet and supernatant from the 100,000 gav spin). The chromaffin granule-
containing 12KP fraction was loaded on a linear sucrose gradient (1m–2.2m) and fractions collected from the top (1–12). 50 µg protein from each fraction 
were separated and analysed by sDs–PAGE and western blotting using the indicated antibodies. The position of the early endosome, plasma membrane 
and secretory granules containing fractions was detected using anti-EEA1, anti-snAP-25 and anti-VAmP2 antibodies, respectively.
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possible explanation could be that sequestration of PtdIns(3,4,5)P3 
prevented the PTEN dephosphorylation of PtdIns(3,4,5)P3 in 
response to IC87114 treatment. Alternatively, overexpression of 
Akt-PH-GFP or Btk-PH-GFP could antagonize PtdIns(3,4,5)P3-
mediated Akt activation as previously shown27, raising the possibil-
ity that Akt might be involved in generating the IC87114-mediated 
rise in PtdIns(4,5)P2. Indeed, pretreatment of chromaffin cells with 
A6730, an Akt inhibitor, blocked this effect (Supplementary Fig. S4). 
This suggests that PI3Kδ signalling through Akt might contribute to 
the control of PTEN activity or have a direct effect on PtdIns(4,5)P2 
production. Altogether, our results suggest that PTEN is involved 
in generating the rise in PtdIns(4,5)P2 evoked by IC87114, an effect 
that is regulated by Akt and/or other kinases. More work is required 
to clarify the mechanism by which IC87114 exerts its effects.
IC87114 shifts the release probability to an earlier release. Hav-
ing characterized the nature of the IC87114-mediated PtdIns(4,5)P2 
signal, we next investigated whether the kinetics of exocytotic 
events was altered by IC87114 using amperometry. We found that 
IC87114 treatment of chromaffin cells significantly increased the 
number of exocytotic events occurring during the initial phase of 
secretion (Fig. 3a,b), resulting in an increase in the size of the releas-
able pool, as previously described8. This effect was also blocked by 
preincubation with VO-OHpic (Fig. 3c,d).
IC87114 promotes vesicle mobilization and translocation. The 
potentiating effect of IC87114 on exocytosis could stem from 
an increased priming of vesicles pre-docked and/or from an 
increased translocation of vesicles to the plasma membrane that, 
when combined with a Ca2 +  signal, could readily increase the 
number of vesicles undergoing fusion. To differentiate between 
these two non-exclusive possibilities, TIRF microscopy was used 
to image chromaffin cells expressing human growth hormone 
fused to GFP (hGH–GFP), a marker stored within neurosecretory 
vesicles. TIRF microscopy is ideal to study vesicle translocation, 
docking and fusion28, as motions in the z-axis can be monitored 
at high resolution via sensitive changes in fluorescence intensity 
within an exponentially decaying evanescent wave of excitation 
light29. We investigated motion and intensity of hGH–GFP-posi-
tive secretory vesicles in cells treated with IC87114. A signifi-
cant increase in the number of vesicles undergoing translocation 
toward the plasma membrane was detected (Fig. 4a,b; Supple-
mentary Movie 3). The bulk of this translocation was transient 
and could not be detected in chromaffin cells pretreated with VO-
OHpic (Fig. 4c,d; Supplementary Movie 4). To exclude the pos-
sibility of an artifactual increase in fluorescence intensity associ-
ated with an overall movement of the cell towards the coverslip, 
we labelled the plasma membrane of cells expressing neuropep-
tide Y (NPY)-mCherry (NPY–Cherry) with FITC-tagged wheat 
germ agglutinin (WGA). This allowed us to confirm that IC87114 
promoted translocation of NPY-positive vesicles without caus-
ing any significant fluorescence change in WGA-labelled plasma 
membrane (Supplementary Fig. S5).
We next attempted to estimate the average displacement of 
secretory vesicles in the TIRF plane upon IC87114 treatment. 
The population of vesicles (~20%) that only appeared in the TIRF 
plane after IC87114 treatment was excluded from our analysis due 
to uncertainty over their starting positions (Fig. 4e). For secretory 
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Figure 2 | IC87114-induced increase in PtdIns(4,5)P2 levels is specific to PI3Kδ and dependent on PTEN activity. mouse chromaffin cells were 
isolated from (a) wild-type (WT) littermate or (b) p110 δD910A/D910A mutant mice and treated with vehicle or IC87114 (1 µm) for 5 min before extracting 
phosphoinositides with acidified chloroform:methanol extraction and probing for PtdIns(4,5)P2 using the anti-PtdIns(4,5)P2 antibody, 2C11. Representative 
TLC blots from 4–6 independent experiments are shown. (c) Cultured bovine chromaffin cells were pre-incubated with or without Vo-oHpic (100 nm) 
in buffer A for 20 min and subsequently treated for 5 min with vehicle alone or IC87114 (1 µm). Phosphoinositides were extracted as described above and 
PtdIns(4,5)P2 levels detected using the 2C11 antibody. A representative example of a TLC blot from 3 independent experiments is shown. Quantification  
of the change in PtdIns(4,5)P2 levels was achieved by densitometry analysis as described in the methods section, and values are expressed as mean ±  
s.e.m. (n = 6 for WT, n = 4 for p110 δD910A/D910A, n = 3 for bovine chromaffin cells, student’s t-test, *P < 0.05). (d,e) Chromaffin cells were transfected with 
PH-PLCδ1-EGFP, and plasma membrane patches were examined by TIRF microscopy at 1 frame per second. Images are displayed in pseudocolour to 
highlight the changes in fluorescence intensity in the indicated conditions. The images shown were taken from the beginning (left) and peak (right) of the 
IC87114-induced effect. The insets display the fluorescence intensity change from a selected region of interest on the plasma membrane patches taken at 
the indicated time points. (f) Time-course variation of PH-PLCδ1-EGFP fluorescence intensity on the (selected) plasma membrane patches in the indicated 
conditions. (g) Average peak fluorescence intensity change of PH-PLCδ1-EGFP in the respective conditions expressed as mean ± s.e.m. (student’s t-test, 
**P < 0.01). scale bar, 10 µm. 
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vesicles that underwent translocation and docking to the plasma 
membrane (Fig. 4f,g), we found that the average distance travelled 
was 158 ± 12 nm (Fig. 4h).
To test whether the translocating vesicles undergo partial or full 
fusion, we used VAMP2-pHluorin, a pH-sensitive form of GFP 
targeted to the luminal part of secretory vesicles that dequench 
on exposure to the extracellular environment28. Bovine chromaf-
fin cells co-expressing NPY–Cherry and VAMP2-pHluorin, were 
treated with IC87114. IC87114 promoted a significant translocation 
of NPY–Cherry to the plasma membrane but no dequenching of 
VAMP2-pHluorin could be detected (Supplementary Fig. S6; Sup-
plementary Movie 5). This suggests that the vesicles mobilized to 
the plasma membrane undergo transient docking but not fusion. 
Control experiment of cells treated with IC87114 and further 
stimulation with barium promoted a significant increase in both 
NPY–Cherry and VAMP2-pHluorin fluorescent signal intensity 
(Supplementary Fig. S6; Supplementary Movie 6).
Actin remodelling is required for vesicle translocation. The corti-
cal actin network in chromaffin cells is known to act as a barrier, 
preventing large dense core vesicles (LDCVs) from accessing the 
plasma membrane. On Ca2 +  entry, the disruption of the corti-
cal actin cytoskeleton allows access of the secretory vesicles to the 
plasma membrane1. Recently, a more active role of the cytoskeleton 
has been suggested3. We hypothesized that the actin cytoskeleton 
might act downstream of PtdIns(4,5)P2 to provide new actin tracks 
for vesicular transport. We first tested the effect of actin disruption 
by cytochalasin D, an inhibitor of actin polymerization29. Pretreat-
ment of chromaffin cells with cytochalasin D prevented IC87114- 
mediated hGH–GFP-positive vesicle translocation to the plasma 
membrane (Fig. 5a; Supplementary Movie 7) without affecting 
the PtdIns(4,5)P2 signal (Fig. 5b; Supplementary Movie 8). This 
suggests that actin could have an active role in mediating this 
IC87114-induced vesicular translocation.
To directly visualize actin tracks, bovine chromaffin cells were 
transfected with Lifeact–RFP, a peptide capable of binding actin 
without perturbing its function30. Lifeact–RFP was found to co-
localize with phalloidin staining of cortical actin (Fig. 6a). Nicotine 
stimulation, which triggers exocytosis by promoting Ca2 +  influx 
into cells, promotes fragmentation and reorganization of cortical 
actin (Fig. 6a, arrows), as previously described1,31. Lifeact staining 
of cortical actin visualized on the footprint of a living chromaf-
fin cells revealed a web-like appearance as previously inferred32  
(Fig. 6b; Supplementary Movie 9). Importantly, Lifeact–RFP expres-
sion did not significantly affect the nicotine-induced hGH release 
from PC12 cells (Fig. 6c). Lifeact is, therefore, a suitable marker for 
imaging F-actin in living neurosecretory cells, which allowed us to 
investigate the effect of IC87114 on actin by TIRF microscopy.
Treatment of chromaffin cells with IC87114 promoted an 
increase in Lifeact–GFP fluorescence by TIRF microscopy (Fig. 
6d,e). This fluorescence-increase was dependent on actin polymeri-
zation as it was blocked by pretreatment with cytochalasin D (Fig. 
6f–i). This indicates that increased levels of PtdIns(4,5)P2 are indeed 
capable of promoting actin remodelling in the immediate vicinity of 
the plasma membrane. To further examine the relationship between 
actin remodelling and vesicle translocation, chromaffin cells were 
co-transfected with Lifeact–GFP and NPY–Cherry to label F-actin 
and LDCVs, respectively. Vesicles undergoing IC87114-induced 
translocation were spatially and temporally associated with actin 
filaments as evidenced in kymographs (Fig. 7a–c).
This rapid remodelling of F-actin pointed to the involvement of 
actin-nucleating factors33. As Cdc42 is required for PtdIns(4,5)P2-
induced actin cytoskeleton remodelling34, we transfected chro-
maffin cells with a WT-Cdc42 or a dominant-negative plasmid 
(Cdc42-T17N)35. Whereas untransfected control cells or expression 
of WT-Cdc42 did not affect the IC87114-mediated vesicle translo-
cation, Cdc42-T17N completely blocked IC87114-induced vesicle 
translocation (Fig. 8a–c), consistent with a role for Cdc42 in medi-
ating actin reorganization in response to increased PtdIns(4,5)P2. 
To further examine the role of Cdc42 in this process, we directly 
measured Cdc42 activity in response to IC87114 treatment in chro-
maffin cells. IC87114 treatment significantly increased Cdc42-GTP 
levels compared with vehicle-treated cells, demonstrating a small 
but significant activation of Cdc42 (Fig. 8d). We also determined 
whether Cdc42 activation could occur in living cells using a Cdc42-
binding domain (CBD) from WASP that binds specifically to the 
active form of Cdc42 (ref. 36). When chromaffin cells co-express-
ing CBD–YFP and mCherry, as a marker for cytosol, were treated 
with IC87114, a recruitment of the domain was detected on specific 
regions of the plasma membrane (Supplementary Fig. S7).
Our data therefore support a growing body of evidence that indi-
cates an important role for actin remodelling in order to mobilize 
and translocate LDCVs to release sites3,35—a process that we reveal 
is controlled by PtdIns(4,5)P2.
Discussion
Using a combination of pharmacological and genetic manipulations, 
we have shown that selective inhibition of PI3Kδ leads to a transient 
increase in PtdIns(4,5)P2 production, at least partly attributed to the 
dephosphorylation of PtdIns(3,4,5)P3 by PTEN. Using this path-
way, we found that PtdIns(4,5)P2 controls the number of secretory 
vesicles available for exocytosis by regulating vesicular mobiliza-
tion, translocation and transient docking to the plasma membrane. 
Our results clearly establish a functional link between PtdIns(4,5)P2 
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Figure 3 | IC87114 promotes an increase in the releasable pool size. 
mouse adrenal chromaffin cells were stimulated with 70 mm K +  solution 
for 1 min (dotted line below trace), and catecholamine release measured 
from single cells using carbon fibre amperometry (a, upper trace). 
Individual current spikes indicate exocytosis from a single vesicle. Pre-
incubation of cells with IC87114 (1 µm) for 2 min before stimulation caused 
a shift in release probability so that more vesicles were released earlier  
(a, bottom trace). This is quantified in (b) and values expressed as mean ±  
s.e.m. (n = 6 cells). (c) Catecholamine release measured using carbon fibre 
amperometry from a control cell (c, upper trace) and a cell treated with 
the combination of Vo-oHpic (100 nm) and IC87114 (c, bottom trace). 
normal secretion was observed in both cases and the treatment did not 
promote a shift in vesicle release probability compared with earlier time 
points (d). Data are expressed as mean ± s.e.m. (n = 8 cells).
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signalling and secretory vesicle dynamics through de novo remodel-
ling of the actin cytoskeleton mediated by Cdc42 activation.
The pan-PI3K inhibitor LY294002 has been shown to exhibit 
a biphasic effect on secretion8: an early phase of potentiation of 
exocytosis followed by an inhibitory phase, which is correlated 
with parallel changes in PtdIns(4,5)P2 levels observed on isolated 
membrane sheets. Here we have identified a likely mechanism 
behind the initial rise in PtdIns(4,5) P2 biphasic effect as being 
triggered by PI3Kδ inhibition, which prevented new produc-
tion of PtdIns(3,4,5)P3 and leading to the dephosphorylation of 
PtdIns(3,4,5)P3 by dis-inhibition of PTEN. Consistent with our 
finding, recent studies have also shown that PI3Kδ can upregulate 
PTEN, leading to an increase in PtdIns(4,5)P2 production19,21. We 
also investigated other potential sources of the IC87114-mediated 
rise in PtdIns(4,5)P2 by examining potential downstream effects of 
PI3K signalling on Akt activity. Selective inhibition of Akt kinase 
by A6730 abolished the IC87114-induced PtdIns(4,5)P2 produc-
tion. Although it is still unclear how Akt regulates PtdIns(4,5)P2 
production, it is plausible that this could occur either by the acti-
vation of PTEN or through an alternative pathway. Interestingly, a 
reduction in PI3K signalling caused by the loss of the PI3K regula-
tory unit p85α was shown to reduce PTEN activity37, supporting 
the notion that PI3K signalling (possibly via Akt) could control 
PTEN activity. Overall, our results are consistent with an effect of 
ControlVehicle
470 86 111 134470 86 111 134
26660
IC87114
996 992
39342
Control
470 86 111 134
VO-OHpic IC87114
1121
9132
hG
H–
G
FP
 fl
uo
re
sc
en
ce
 in
te
ns
ity
(%
 of
 in
itia
l)
VO-OH+
IC87114
IC87114
Vehicle
0 20 40 60 80 100 120 140
60
80
100
120
140
160
25 s7
50
 a
.u
. 
∆F
∆t
tR
 
Time (s)
0 50 100 150 200 250
0.0
0.2
0.4
0.6
0.8
1.0
1.2
M
SD
 (µ
m
2  
)
Distance travelled (nm)
0 100 200 300
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
400
Pr
ob
ab
ilit
y
Coverslip
Membrane
20 ± 1 %
158 ± 12 nm
400 nm
> 400 nm80 ± 1 %
Figure 4 | IC87114 promotes an active translocation of secretory vesicles to the plasma membrane dependent on PTEN activity. Bovine chromaffin 
cells expressing hGH–GFP were examined by TIRF microscopy and imaged at 1 frame per second while being treated with either (a) vehicle alone 
or IC87114 (1 µm) in the presence (b) or absence (c) of Vo-oHpic (100 nm). Images taken before and at the peak of treatment are displayed in 
pseudocolour. A representative example of chromaffin cells from at least three independent experiments is shown. The insets show the fluorescence 
intensity change of identified vesicles in the above-mentioned conditions. (d) The time-course variations of the overall hGH–GFP fluorescence intensity 
expressed as a percentage of the initial intensity (n = 3–8 randomly chosen regions of interest per condition). (e) Cartoon illustrating the results of the 
vertical displacement analysis of secretory vesicles in response to IC87114 treatment. The calculation of vesicle displacement to the plasma membrane in 
the evanescent field was derived from the calibration of the evanescent field (see methods). Vesicles not detectable before treatment, but that underwent 
translocation to the plasma membrane in response to IC87114 (20 ± 1% of the secretory vesicles (n = 10 cells)), were excluded from our displacement 
analysis because of the uncertainty over their original positions. Vesicles that were already present in the evanescent field (~400 nm) were found to 
travel on average 158 ± 12 nm (n = 53 vesicles from 8 cells) to the plasma membrane in response to IC87114 treatment. note that only vesicles fast 
approaching and residing on the plasma membrane for more than 10 s (tR > 10 s) were taken into consideration to avoid contamination from free-moving 
vesicles randomly moving towards the plasma membrane without reaching it, as described previously52. (f) Time-course of the fluorescence intensity of 
a tracked nPY–Cherry-positive vesicle. Changes in fluorescence intensity (∆F) were used to calculate its penetration depth. (g) Plot of the mean square 
displacement versus time interval for the tracked vesicle in (f). note that all the vesicles travelling to the plasma membrane underwent directed motion 
before reaching the plasma membrane. (h) Probability distribution of the IC87114-induced secretory vesicle displacement to the plasma membrane.
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PI3Kδ inhibition on PtdIns(4,5)P2 levels through direct or indi-
rect (Akt-mediated) activation of PTEN.
We found evidence of non-homogeneous PtdIns(4,5)P2 clus-
ters on the plasma membrane as previously described8,38. Some of 
these PtdIns(4,5)P2 clusters were more sensitive to IC87114, as evi-
denced by a greater increase in PtdIns(4,5)P2 levels compared with 
elsewhere on the plasma membrane. This inhomogeneity could 
result from local conversion of PtdIns(3,4,5)P3 within PtdIns(4,5)P2 
clusters and/or a non-homogeneous distribution of PTEN/PI3Kδ 
on the plasma membrane.
Our current findings also demonstrate that PI3Kδ is expressed 
in adrenal chromaffin cells in both early endosomal-containing 
fractions and the plasma membrane. This isoform could therefore 
have a role in early endosomal function, as previously suggested for 
p110β39. Importantly, there is an overlap between PTEN and PI3Kδ 
in the plasma membrane-enriched fractions. PTEN localization on 
the plasma membrane is regulated by RhoA and RhoA-associated 
kinase activity36 and inhibition of PI3Kδ has previously been shown 
to activate RhoA and RhoA-associated kinase activity19. Therefore, 
PI3Kδ inhibition could potentially promote PTEN recruitment to 
the plasma membrane and enhance its phosphatase activity, thereby 
increasing PtdIns(4,5)P2 levels. Importantly, Myosin 5 also controls 
PTEN translocation to the plasma membrane in neurosecretory 
cells and hippocampal neurons37. Although our study does not cover 
the mechanism responsible for PTEN translocation, we detected 
PTEN in the secretory vesicle fraction, which is also controlled 
by Myosin-5 (ref. 40). Altogether, this points to a role of secretory 
vesicle exocytosis in delivering PTEN to the plasma membrane, but 
more work is needed to clarify this issue.
The IC87114-mediated increase in PtdIns(4,5)P2 was suf-
ficient to promote both the active translocation of secretory 
vesicles to the plasma membrane and, in the presence of stimu-
lation, the fusion of an increased number of secretory vesicles. 
There is an apparent discrepancy between the transient nature 
of the effect of PtdIns(4,5)P2 on actin polymerization and the 
long-lasting potentiating effect induced by IC87114. Although 
the mechanism underlying this discrepancy is not clear, it is 
possible that acute changes in PtdIns(4,5)P2 levels could not 
only affect actin polymerization as demonstrated herein, but 
could also be sufficient to prime a pool of secretory vesicles by 
signalling through an array of downstream effectors important 
for priming. In this view, an increase in PTEN activity is likely 
to stimulate phospholipase D activity41 thereby promoting the 
production of phosphatidic acid, a fusogenic lipid critical for 
the late stages of Ca2 + -regulated exocytosis in neurosecretory 
cells42. Therefore, the inhibition of PI3Kδ by IC87114 is likely to 
induce further effects to alter evoked secretion that persist well 
beyond the transient change observed in PtdIns(4,5)P2 levels and 
actin polymerization.
Using Lifeact–GFP and TIRF microscopy, we have demonstrated 
that a rise in PtdIns(4,5)P2 is sufficient to promote polymerization/
remodelling of F-actin in the immediate vicinity of the plasma mem-
brane in neurosecretory cells. Consistent with our findings, expres-
sion of PI4P5K Iα has also been shown to induce actin remodelling 
in COS-7 cells43. Hypertonic stress, which increases PtdIns(4,5)P2 
levels by activating PI4P5K Iβ, also produces actin polymerization 
and reorganization44. Our finding that 20 ± 1% of vesicles translocate 
to the plasma membrane from outside the evanescent field following 
IC87114 treatment, and that vesicles undergoing translocation and 
transient docking exhibit a directed motion consistent with trans-
port along F-actin, support a growing body of evidence highlight-
ing the role of actin filaments in guiding LDCVs to release sites3,35. 
An alternative model for the IC87114-induced vesicular transloca-
tion could involve the PtdIns(4,5)P2-induced actin polymerization 
helping to push the vesicles towards the plasma membrane. Due to 
the short distances travelled by the vesicles originally present in the 
evanescent field, we are currently unable to conclusively distinguish 
between the two theories.
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Figure 5 | Cytochalasin D prevents the IC87114-mediatd secretory vesicle translocation to the plasma membrane. Bovine chromaffin cells expressing 
(a) hGH–GFP or (b) PH-PLCδ1-EGFP were briefly washed with buffer A before incubation with cytochalasin D (2 µm) for 20 min. Cells were examined 
by TIRF microscopy and imaged at 1 frame per second before and after the addition of IC87114 (1 µm). The images shown in pseudocolour are taken 
at the beginning (left) and the peak (right) of the IC87114-induced effect. The time-course of the changes in hGH-GFP or PH-PLCδ1-EGFP fluorescence 
intensity is expressed as percentage of the initial fluorescence intensity (n = 5–7 regions of interest per condition). Average peak fluorescence increases 
in the indicated conditions are expressed as mean ± s.e.m. (n = 7 hGH-GFP expressing cells and n = 3–5 PH-PLCδ1-EGFP expressing cells. student’s t-test, 
**P < 0.01). scale bar, 10 µm.
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Cdc42, neural Wiskott–Aldrich syndrome protein and Arp2/3 
have been proposed to remodel F-actin, a process that helps to 
drive neuroexocytosis3. Our findings that IC87114 treatment sig-
nificantly activates Cdc42, and that expression of Cdc42DN inhibits 
PtdIns(4,5)P2-mediated vesicle translocation, indicate that Cdc42 
acts as a co-regulator of neural Wiskott–Aldrich syndrome protein45 
to promote local actin polymerization at the plasma membrane. 
The increased Cdc42 activation could stem from an increase in 
PtdIns(4,5)P2 pools and/or a reduction in PtdIns(3,4,5)P3 concen-
trations, as previously suggested46. In view of the previous finding 
that Cdc42 facilitates exocytosis in chromaffin cells by stimulating 
actin polymerization in the vicinity of vesicle docking sites35, our 
data provide a possible link between PtdIns(4,5)P2 signalling and 
Cdc42-mediated actin reorganization in the transport of vesicles to 
the plasma membrane.
Although outside the scope of the present study, it would be 
worth testing whether Myosin-5a could be the actual molecular 
motor involved in the IC87114-mediated translocation of secretory 
granules to the plasma membrane40. Our estimation of the speed of 
the translocating vesicles (11.5 ± 1.1 nm s − 1) is slower than that pre-
viously reported for vesicles under depolarization (34 ± 17 nm s − 1)28. 
One explanation is that the absence of Ca2 +  fails to activate Ca2 +  
effectors such as scinderin47, which normally contribute to the 
translocation of secretory vesicles via their loosening effect on 
the cortical actin network. In conclusion, our results establish a 
functional link between PtdIns(4,5)P2 signalling and secretory vesi-
cle translocation to the plasma membrane through the control of 
cortical actin.
Methods
Catecholamine release from bovine adrenal chromaffin cells. Adrenal chromaf-
fin cells were extracted from adrenal medulla and cultured48,49. Cells were washed 
in buffer A (in mM: NaCl, 145; KCl, 5; Na2HPO4, 1.2; glucose, 10; HEPES–NaOH, 
20; pH 7.4) and pre-incubated with the indicated concentrations of IC87114 before 
being stimulated with or without barium (2 mM) in buffer A. In some cases, cells 
were stimulated by digitonin (20 µM) permeabilization in KGEP buffer (in mM: 
K-glutamate, 139; glucose, 5; EGTA, 5; PIPES–NaOH, 20; pH 6.7) containing 2 mM 
free Mg2 + , 2 mM ATP and 10 µM free Ca2 +  for 3 min. At the end of each experi-
ment, aliquots of supernatant were taken and the cells were further lysed with 1% 
(v/v) Triton X-100 (Sigma). Both sets of samples were assayed fluorometrically for 
catecholamine content.
hGH release from transfected PC12 cells. PC12 cells were transfected with 
pXGH5 vector-encoding hGH and indicated constructs for 48 h. Cells were washed 
and stimulated with or without nicotine (50 µM) in buffer A containing 2 mM CaCl2 
for 15 min before collecting supernatant aliquots. Cells were then lysed with 1% 
Triton X-100 for measurement of total hGH. The amount of hGH secretion was ana-
lysed using an hGH ELISA kit (Roche) according to the manufacturer’s instructions.
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Chromaffin cell labelling. Freshly isolated chromaffin cells (4×106 cells per well) 
were transfected by electroporation with the indicated plasmids (2 µg per well) 
using an Amaxa Rat Neuron Nucleofector Kit (Lonza). After 48–72 h, cells were 
washed and stimulated with or without nicotine (50 µM) in buffer A containing 
2 mM CaCl2. They were then fixed with 4% paraformaldehyde for 30 min, washed 
with PBS and incubated with blocking buffer (0.05% Triton X-100, 0.5% bovine 
serum albumin (BSA), 3% normal horse serum) for 1 h. Cells were stained with 
FITC-phalloidin (1 mg ml − 1) (Sigma) in PBS for 30 min and coverslips mounted 
with Prolong Gold (Molecular Probes) before being visualized using a LSM 510 
confocal microscope (Carl Zeiss).
Bovine adrenal medulla fractionation. Isolated medulla were homogenized 
in 0.32 M sucrose in 10 mM Tris, 1 mM EGTA pH 7.4, and subjected to 800gav 
centrifugation for 2×15 min. The supernatant was then re-centrifuged for 20 min 
at 12,000 gav, after which the pellet (12KP) was resuspended in 0.32 M sucrose 
in 10 mM Tris, 1 mM EGTA pH 7.4 and loaded on a linear sucrose gradient 
(1M–2.2M) before being centrifuged for 1 h at 100,000 gav. 12×1 ml fractions were 
collected from the top of the gradient. The supernatant from the 12,000 gav spin 
(12KSN) was further separated by centrifugation for 1 h at 100,000gav, after which 
the pellet and supernatant were collected (100KP and 100KSN). For western blot-
ting, 50 µg of each fraction was solubilized in Laemmli sample buffer and heated 
for 3 min at 95 °C before loading on an SDS–PAGE gel. Proteins were transferred 
to Immobilon-FL polyvinylidene difluoride (PVDF-FL) blotting membranes 
(Millipore) and probed with primary antibodies (anti-p110δ, 1/1,000; anti-PTEN, 
1/2,000) and detected using the Odyssey Infrared Imaging System (LI-COR Bio-
sciences) according to the manufacturer’s instructions.
Rodent adrenal chromaffin cells isolation. In each experiment, 4–8 adrenal 
glands were taken from age-matched adult C57BL/6 mice with approval from the 
University of Queensland and Flinders University Animal Ethics Committees, and 
in accordance with the National Health and Medical Research Council of Australia 
guidelines. The isolated chromaffin cells44,45 were either directly used for lipid 
analysis or cultured in Dulbecco’s modified Eagle’s Medium supplemented with 1% 
penicillin/streptomycin (Invitrogen) and 10% fetal calf serum (JRH Biosciences) 
and plated on tissue culture dishes (35 mm, Nunclon) for 3–4 days before  
experiments.
Amperometry. Catecholamine release from single chromaffin cells was measured 
using amperometry50 by applying  + 800 mV to a carbon-fibre electrode (ProCFE, 
Dagan), and recording the resultant current (EPC-9 amplifier and Pulse software, 
HEKA Electronik), sampled at 10 kHz and low-pass filtered at 1 kHz. Spikes were 
analysed (Mini Analysis, 6.0.1, Synaptosoft) for a period of 60 s. The bath solution 
contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM d-glu-
cose and 10 mM HEPES, pH 7.4. The stimulating solution contained 70 mM K +  
replacing an equimolar amount of NaCl. Experiments were conducted at 30–32 °C 
using an in-line solution heater (Warner Instruments). Amperometric spikes were 
selected, if spike amplitude exceeded 2.5 times the root-mean-squared baseline 
noise. Cells with 10–200 events were used for the analysis.
Lipid extraction and analysis. Bovine/mouse chromaffin cells were treated with 
1 M HCl at the end of the treatment. Lipids were extracted by the addition of 
chloroform (CHCl3): methanol (MeOH) (1:1, v/v) and 2 M potassium chloride to 
the acidified samples. The lower organic phase was collected and dried under a 
low stream of nitrogen. Dried lipids were resuspended in the lower organic phase 
and spotted on oxalate-treated TLC plates (Merck). Lipids were separated on TLC 
plates in a pre-equilibrated glass tank containing CHCl3: MeOH: dH2O: NH4OH 
(30%) (9:7:1:1 v/v). TLC plates were dried overnight before processing for the 
overlay assay. For this assay, the TLC plates were blocked in 2.5% BSA ( > 98% fatty 
acid free, Sigma) in PBS for 2 h at room temperature. Anti-PtdIns(4,5)P2 antibody 
2C11 (2.45 µg ml − 1; Echelon Biosciences) was added to the blocking buffer for an 
extra 2 h. Plates were extensively washed with PBS and incubated with anti-mouse 
HRP-conjugated secondary antibodies (1/500) for 1 h in 1% BSA, washed in PBS 
and the signal detected using Supersignal West Pico (Pierce).
HPLC-based lipid analysis. Bovine chromaffin cells were labelled with 
0.3 mCi ml − 1 inorganic 32P for 2 h at 37 °C in phosphate-free Dulbecco’s modified 
Eagle’s Medium (Invitrogen) supplemented with 10% serum supreme (Lonza) and 
10 mM HEPES. Unincorporated 32P was removed by briefly washing cells with 
buffer A. Cells were incubated with DMSO or IC87114 (1 µM) for 5 min before 
the reaction was stopped by placing on ice and the adherent cells removed using a 
cell scraper. Lipids were extracted by the sequential addition of 96% MeOH/CHCl3 
(2:1, v/v), 3.14% (v/v) Milli-Q water and CHCl3 containing Folch extract (Sigma) 
and 2.4 M HCl, 5 mM tetrabutylammonia sulfate. The inorganic phase was col-
lected and dried under vacuum. For deacylation, dried lipids were resuspended 
in methylamine solution (40% methylamine: butanol: MeOH (42:9:47, v/v/v) and 
dried at 53 °C in the fume hood. Deacylated samples were then resuspended in 
0.5 ml Milli-Q water and extracted with a solution containing butanol/petroleum 
ether (40–60): ethyl formate (20:4:1, v/v/v). The aqueous phase was collected  
and dried under vacuum and resuspended in Milli-Q and 32P-labelled  
phosphoinositides were separated by HPLC using a partisphere SAX-HPLC col-
umn (Whatman, 4.6 mm×125 mm)25.
Total internal reflection fluorescence microscopy imaging. Isolated bovine 
chromaffin cells were transfected with respective plasmids by electroporation 
(program X-001) using the Amaxa Rat Neuron Nucleofector Kit (Lonza). Cells 
were cultured on glass-bottomed culture dishes (MatTek) for 48–72 h before 
visualizing using a TIRF microscope (Marianas, SDC Everest, Intelligent Imaging 
Innovations) fitted with a X100 oil immersion objective (NA = 1.46, Zeiss) using an 
EMCCD camera (QuantEM 512sc). Cells were bathed in buffer A before the addi-
tion of IC87114 (Symansis), VO-OHpic (kind gift from Dr. Rudiger Woscholski, 
Imperial Colleague London), cytochalasin D (Sigma) or A6730 (Sigma) and a 
time-lapse movie was captured at 1 frame per second for the indicated period. 
Length of Lifeact–GFP actin fibres was measured using the Slidebook software 
(version 4.2.0.13).
Calibration of evanescent field. Fluoresbrite Plain Microspheres (Polysciences) 
of 2 µm diameter were allowed to settle on the glass-bottom culture MatTek dishes 
and visualized by TIRF microscopy51. The beads located at the glass–water interface 
were imaged and z-stack TIRF images taken at 0.01 µm interval. Images were 
analysed to determine the centre of mass of the bead using 2D-Gaussian fitting of 
the intensity profile using MATLAB (Mathworks). Using the spherical shape of the 
beads, the distance to the centre of mass was related to the penetration depth of the 
fluorophore. The exponential decay relationship between fluorescence intensity and 
the penetration depth was then plotted, and the best fitting parameters were used 
to estimate the penetration depth (n = 10 beads).
Cdc42 activation assay. Lysates from bovine chromaffin cultures treated for 
20 min with DMSO or IC87114 (1 µM) were assayed for Cdc42 activation using 
a Cdc42 activation kit, according to the manufacturer’s instructions (Millipore). 
Controls for in vitro GTPγS/GDP loading were prepared by incubation with 
1 mM EDTA at 30 °C for 15 min in the presence of 1 mM GDP (negative control) 
or 100 µM GTPγS (positive control). 10 µg of PAK-1 agarose beads were added 
to all cleared lysates. Precipitates were washed three times before resuspension in 
Laemmli sample buffer. Cleared lysates and precipitates from negative and positive 
controls, DMSO or IC87114 treatments were resolved by SDS–PAGE before west-
ern blotting using anti-Cdc42 (1 µg ml − 1) (Odyssey Infrared Imaging System).
Statistical analysis. Data analysis was carried out using Student’s t-test. All ex-
periments were repeated at least three times. Values are expressed as mean ± s.e.m. 
and data were considered significant at *P < 0.05; **P < 0.01. 
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